EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune cell topography of head and neck cancer

Tara Muijlwijk iD, Dennis N L M Nijenhuis, Sonja H Ganzevles, Fatima Ekhlas, Carmen Ballesteros-Merino, Laura A N Peferoen, Elisabeth Bloemena, Bernard A Fox iD, Jos B Poell, C René Leemans, Ruud H Brakenhoff, Rieneke van de Ven iD

Journal for ImmunoTherapy of Cancer · 2024-07 · 12 (7) · e009550

DOI: 10.1136/jitc-2024-009550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 24.07.2024. Verfasst von Tara Muijlwijk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology / Head and Neck Surgery, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Head and Neck Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society grant, Cancer Center Amsterdam, Amsterdam UMC Young Talent fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond. To increase this response rate, it is fundamental to increase our understanding of the spatial tumor immune microenvironment (TIME).

Methods

In total, 53 HNSCC specimens were included. Using a seven-color multiplex immunohistochemistry panel we identified tumor cells, CD163+macrophages, B cells, CD8+T cells, CD4+T helper cells and regulatory T cells (Tregs) in treatment-naive surgical resection specimens (n=29) and biopsies (n=18). To further characterize tumor-infiltrating CD8+T cells, we stained surgical resection specimens (n=12) with a five-color tumor-resident panel including CD103, Ki67, CD8 and pan-cytokeratin. Secretome analysis was performed on matched tumor suspensions (n=11) to measure protein levels.

Results

Based on CD8+T cell infiltrates, we identified four different immunotypes: fully infiltrated, stroma-restricted, immune-excluded, and immune-desert. We found higher cytokine levels in fully infiltrated tumors compared with other immunotypes. While the highest immune infiltrates were observed in the invasive margin for all immune cells, CD163+macrophages and Tregs had the highest tendency to infiltrate the tumor center. Within the tumor center, especially B cells stayed at the tumor stroma, whereas CD163+macrophages, followed by T cells, were more often localized within tumor fields. Also, B cells were found further away from other cells and often formed aggregates while T cells and CD163+macrophages tended to be more closely located to each other. Across resection specimens from various anatomical sites within the head and neck, oral cavity tumors exhibited the highest densities of Tregs. Moreover, the distance from B cells and T cells to tumor cells was shortest in oral cavity squamous cell carcinoma (OCSCC), suggesting more interaction between lymphocytes and tumor cells. Also, the fraction of T cells within 10 µm of CD163+macrophages was lowest in OCSCC, indicating fewer myeloid/T-cell suppressive interactions in OCSCC.

Conclusions

We comprehensively described the TIME of HNSCC using a unique data set of resection specimens. We discovered that the composition, as well as the relative localization of immune cells in the TIME, differed in distinct anatomical sites of the head and neck.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsHumansMaleFemaleTumor MicroenvironmentMiddle AgedSquamous Cell Carcinoma of Head and NeckAgedMacrophagesLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

B cellHead and Neck CancerMacrophageT cellTumor microenvironment - TME

Autor:innen und Institutionen

  • Otolaryngology / Head and Neck Surgery, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.
  • Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands.
  • Cancer Immunology, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
  • Molecular and Tumor Immunology Laboratory, Providence Cancer Institute, Robert W. Franz Research Center at the Earle A. Chiles Research Institute, Portland, Oregon, USA.
  • Pathology, Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands.
  • Maxillofacial Surgery/ Oral Pathology, Academic Center for Dentistry, Amsterdam, The Netherlands.

ORCID-Profile: Tara Muijlwijk, Bernard A Fox, Rieneke van de Ven

Förderung

  • Dutch Cancer Society grant
  • Cancer Center Amsterdam
  • Amsterdam UMC Young Talent fund

Zitieren

APA

Muijlwijk, T., Nijenhuis, D. N. L. M., Ganzevles, S. H., Ekhlas, F., Ballesteros-Merino, C., Peferoen, L. A. N., Bloemena, E., Fox, B. A., Poell, J. B., Leemans, C. R., Brakenhoff, R. H., & van de Ven, R. (2024). Immune cell topography of head and neck cancer. Journal for ImmunoTherapy of Cancer, 12(7), e009550. https://doi.org/10.1136/jitc-2024-009550

Vancouver

Muijlwijk T, Nijenhuis DNLM, Ganzevles SH, Ekhlas F, Ballesteros-Merino C, Peferoen LAN, et al. Immune cell topography of head and neck cancer. Journal for ImmunoTherapy of Cancer. 2024;12(7):e009550. doi:10.1136/jitc-2024-009550

BibTeX
@article{Muijlwijk2024,
  author = {Muijlwijk, Tara and Nijenhuis, Dennis N L M and Ganzevles, Sonja H and Ekhlas, Fatima and Ballesteros-Merino, Carmen and Peferoen, Laura A N and Bloemena, Elisabeth and Fox, Bernard A and Poell, Jos B and Leemans, C René and Brakenhoff, Ruud H and van de Ven, Rieneke},
  title = {Immune cell topography of head and neck cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {7},
  pages = {e009550},
  doi = {10.1136/jitc-2024-009550}
}
Kostenlos starten →